Shares of Medical Properties Trust, Inc. (NYSE:MPW - Get Free Report) have been given an average rating of "Hold" by the seven ratings firms that are covering the company, MarketBeat.com reports. Six equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average twelve-month price target among brokers that have covered the stock in the last year is $4.92.
Several equities analysts have recently commented on the company. Truist Financial decreased their target price on Medical Properties Trust from $6.00 to $4.00 and set a "hold" rating on the stock in a research report on Thursday, December 19th. Colliers Securities raised Medical Properties Trust from a "neutral" rating to a "buy" rating and set a $6.50 price objective on the stock in a report on Friday, September 13th. Wolfe Research raised Medical Properties Trust to a "hold" rating in a report on Monday, September 23rd. Finally, Mizuho decreased their price target on shares of Medical Properties Trust from $6.00 to $5.00 and set a "neutral" rating on the stock in a research note on Thursday, December 5th.
View Our Latest Analysis on Medical Properties Trust
Medical Properties Trust Stock Performance
Shares of MPW stock traded up $0.13 during midday trading on Friday, hitting $4.15. 9,149,341 shares of the company were exchanged, compared to its average volume of 11,364,271. Medical Properties Trust has a 52 week low of $2.92 and a 52 week high of $6.55. The firm has a market capitalization of $2.49 billion, a P/E ratio of -0.98, a PEG ratio of 0.62 and a beta of 1.29. The firm's 50 day moving average price is $4.22 and its two-hundred day moving average price is $4.68. The company has a debt-to-equity ratio of 1.69, a quick ratio of 2.38 and a current ratio of 2.38.
Medical Properties Trust Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, January 9th. Stockholders of record on Thursday, December 12th will be given a $0.08 dividend. This represents a $0.32 annualized dividend and a dividend yield of 7.71%. The ex-dividend date of this dividend is Thursday, December 12th. Medical Properties Trust's payout ratio is presently -7.58%.
Insider Buying and Selling
In related news, Director Michael G. Stewart sold 32,780 shares of the company's stock in a transaction on Wednesday, October 9th. The stock was sold at an average price of $5.46, for a total transaction of $178,978.80. Following the completion of the sale, the director now directly owns 221,245 shares in the company, valued at $1,207,997.70. This represents a 12.90 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CAO James Kevin Hanna sold 11,641 shares of Medical Properties Trust stock in a transaction dated Thursday, December 26th. The shares were sold at an average price of $3.72, for a total value of $43,304.52. Following the completion of the transaction, the chief accounting officer now owns 366,913 shares in the company, valued at approximately $1,364,916.36. This represents a 3.08 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 47,421 shares of company stock worth $233,293. Corporate insiders own 1.53% of the company's stock.
Hedge Funds Weigh In On Medical Properties Trust
Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Ables Iannone Moore & Associates Inc. grew its holdings in shares of Medical Properties Trust by 3.4% during the third quarter. Ables Iannone Moore & Associates Inc. now owns 58,707 shares of the real estate investment trust's stock worth $343,000 after purchasing an additional 1,939 shares during the last quarter. KG&L Capital Management LLC grew its holdings in Medical Properties Trust by 5.3% during the 3rd quarter. KG&L Capital Management LLC now owns 50,875 shares of the real estate investment trust's stock worth $298,000 after acquiring an additional 2,550 shares during the last quarter. Arizona State Retirement System grew its holdings in Medical Properties Trust by 1.9% during the 2nd quarter. Arizona State Retirement System now owns 167,722 shares of the real estate investment trust's stock worth $723,000 after acquiring an additional 3,103 shares during the last quarter. GAMMA Investing LLC increased its position in Medical Properties Trust by 107.3% in the 3rd quarter. GAMMA Investing LLC now owns 6,077 shares of the real estate investment trust's stock valued at $36,000 after acquiring an additional 3,145 shares during the period. Finally, Commerce Bank raised its stake in shares of Medical Properties Trust by 4.0% during the third quarter. Commerce Bank now owns 89,058 shares of the real estate investment trust's stock valued at $521,000 after acquiring an additional 3,435 shares during the last quarter. Institutional investors own 71.79% of the company's stock.
Medical Properties Trust Company Profile
(
Get Free ReportMedical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.
Further Reading
Before you consider Medical Properties Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medical Properties Trust wasn't on the list.
While Medical Properties Trust currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.